Wednesday, February 10, 2010
  • Font size
  • Bookmark
  • Save
Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

FDA approves new treatment for bipolar I disorder

(Reuters) UPDATED 2009-05-18
The U.S. Food and Drug Administration has approved Risperdal Consta for the treatment of bipolar I disorder. The drug was approved both as a stand-alone therapy or as an add-on treatment to lithium or valproate, the current standard of care for people with this condition. Risperdal Consta has already been approved in the United States as a treatment for schizophrenia and bipolar mania.  Read full story >
See all Bipolar News
Related: Risperdal
  • Font size
  • Bookmark
  • Was this helpful? Yes
  • Save

People who read this also read...